UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Modelling approaches for angiogenesis

European journal of cancer (1990), 2004-04, Vol.40 (6), p.881-889

2004

Link zum Volltext

Verfügbarkeit prüfen

Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 ( ) autocrine loop in human leukemia cells MOLT-4

Leukemia, 2003-01, Vol.17 (1), p.52-59

2003

Link zum Volltext

Verfügbarkeit prüfen

980: Identification of potential biomarkers in pancreatic ductal adenocarcinoma associated to tumor–stroma interaction

European journal of cancer (1990), 2014-07, Vol.50, p.S239-S239

2014

Link zum Volltext

Verfügbarkeit prüfen

PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1

Thrombosis research, 2016-04, Vol.140, p.S182-S182

2016

Link zum Volltext

Verfügbarkeit prüfen

The microtubule-affecting drug paclitaxel has antiangiogenic activity

Clinical cancer research, 1996-11, Vol.2 (11), p.1843-1849

1996

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic and antivascular therapy for cancer

Current Opinion in Pharmacology, 2001-08, Vol.1 (4), p.378-384

2001

Link zum Volltext

Verfügbarkeit prüfen

Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel

British journal of cancer, 2007-10, Vol.97 (7), p.888-894

2007

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases

JNCI : Journal of the National Cancer Institute, 1995-02, Vol.87 (4), p.293-298

1995

Link zum Volltext

Verfügbarkeit prüfen

940 Cediranib Affects Tumor Progression and Survival of Mice Bearing Human Ovarian Carcinoma Xenografts Expressing VEGFC

European journal of cancer (1990), 2012-07, Vol.48, p.S226-S226

2012

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic activity of aplidine, a new agent of marine origin

British journal of cancer, 2004-06, Vol.90 (12), p.2418-2424

2004

Link zum Volltext

Verfügbarkeit prüfen

The heparin binding 25 kDa fragment of thrombospondin‐1 promotes angiogenesis and modulates gelatinase and TIMP‐2 production in endothelial cells

The FASEB journal, 2000-09, Vol.14 (12), p.1674-1676

2000

Link zum Volltext

Verfügbarkeit prüfen

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma

European journal of cancer (1990), 2003-09, Vol.39 (13), p.1948-1956

2003

Link zum Volltext

Verfügbarkeit prüfen

Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression

Thrombosis research, 2012-04, Vol.129, p.S193-S193

2012

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of FGF-2 angiogenic activity by novel small molecules mimetic of thrombospondin-1 (TSP-1)

Thrombosis research, 2012-04, Vol.129, p.S193-S193

2012

Link zum Volltext

Verfügbarkeit prüfen

PO-76 The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature

Thrombosis research, 2021-04, Vol.200, p.S58-S59

2021

Link zum Volltext

Verfügbarkeit prüfen

Shedding of the Matrix Metalloproteinases MMP-2, MMP-9, and MT1-MMP as Membrane Vesicle-Associated Components by Endothelial Cells

The American journal of pathology, 2002-02, Vol.160 (2), p.673-680

2002

Link zum Volltext

Verfügbarkeit prüfen

Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: Implications for ascites formation

Cancer research (Chicago, Ill.), 2003-09, Vol.63 (17), p.5224-5229

2003

Link zum Volltext

Verfügbarkeit prüfen

Platelet Thrombospondin Modulates Endothelial Cell Adhesion, Motility, and Growth: A Potential Angiogenesis Regulatory Factor

The Journal of cell biology, 1990-08, Vol.111 (2), p.765-772

1990

Link zum Volltext

Verfügbarkeit prüfen

Functional domains of the 67-kDa laminin receptor precursor

The Journal of biological chemistry, 1991-10, Vol.266 (30), p.20440-20446

1991

Link zum Volltext

Verfügbarkeit prüfen

Bioavailability of VEGF in Tumor-Shed Vesicles Depends on Vesicle Burst Induced by Acidic pH

Neoplasia (New York, N.Y.), 2006-02, Vol.8 (2), p.96-103

2006

Link zum Volltext

Verfügbarkeit prüfen

Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice

Journal of the American Society of Nephrology, 1997-05, Vol.8 (5), p.720-729

1997

Link zum Volltext

Verfügbarkeit prüfen

Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo

The American journal of pathology, 2000-11, Vol.157 (5), p.1703-1711

2000

Link zum Volltext

Verfügbarkeit prüfen

Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts

Clinical cancer research, 1998-04, Vol.4 (4), p.985-992

1998

Link zum Volltext

Verfügbarkeit prüfen

Shedding of membrane vesicles by tumor and endothelial cells

Italian journal of anatomy and embryology, 2005, Vol.110 (2 Suppl 1), p.127

2005

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies

Neoplasia (New York, N.Y.), 2012-09, Vol.14 (9), p.846-IN16

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(86)
Sonstige
(1)

Sprache

Englisch
(87)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(55)
Biological And Medical Sciences
(48)
Humans
(46)
Animals
(40)
Medical Sciences
(34)
Oncology
(33)
Mice
(28)
Female
(21)
Tumors
(18)
Antineoplastic Agents
(15)
Cells, Cultured
(15)
Fundamental And Applied Biological Sciences. Psychology
(14)
Pharmacology. Drug Treatments
(14)
Cell Movement - Drug Effects
(13)
Endothelium, Vascular - Cytology
(13)
Angiogenesis
(12)
Cell Biology
(12)
Cell Division - Drug Effects
(11)
Mice, Nude
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Modelling approaches for angiogenesis

Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 ( ) autocrine loop in human leukemia cells MOLT-4

980: Identification of potential biomarkers in pancreatic ductal adenocarcinoma associated to tumor–stroma interaction

PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1

The microtubule-affecting drug paclitaxel has antiangiogenic activity

Antiangiogenic and antivascular therapy for cancer

Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel

Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases

940 Cediranib Affects Tumor Progression and Survival of Mice Bearing Human Ovarian Carcinoma Xenografts Expressing VEGFC

Antiangiogenic activity of aplidine, a new agent of marine origin

The heparin binding 25 kDa fragment of thrombospondin‐1 promotes angiogenesis and modulates gelatinase and TIMP‐2 production in endothelial cells

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma

Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression

Inhibition of FGF-2 angiogenic activity by novel small molecules mimetic of thrombospondin-1 (TSP-1)

PO-76 The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature

Shedding of the Matrix Metalloproteinases MMP-2, MMP-9, and MT1-MMP as Membrane Vesicle-Associated Components by Endothelial Cells

Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: Implications for ascites formation

Platelet Thrombospondin Modulates Endothelial Cell Adhesion, Motility, and Growth: A Potential Angiogenesis Regulatory Factor

Functional domains of the 67-kDa laminin receptor precursor

Bioavailability of VEGF in Tumor-Shed Vesicles Depends on Vesicle Burst Induced by Acidic pH

Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice

Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo

Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts

Shedding of membrane vesicles by tumor and endothelial cells

Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies

Suchergebnisse filtern